| 1 |
34813529 | Bempedoic acid: LDL-C lowering without adverse reactions. | 2021 Dec 1 |
1 |
| 2 |
30740643 | Safety and efficacy of ETC-1002 in hypercholesterolaemic patients: a meta-analysis of randomised controlled trials. | 2019 |
2 |
| 3 |
29609755 | Bempedoic Acid (ETC-1002): A Current Review. | 2018 May |
2 |
| 4 |
29910030 | Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: A randomized, placebo-controlled study. | 2018 Oct |
3 |
| 5 |
27206943 | Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intolerance. | 2016 May-Jun |
2 |
| 6 |
27663902 | Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase. | 2016 Oct |
4 |
| 7 |
24978142 | LDL-cholesterol reduction in patients with hypercholesterolemia by modulation of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase. | 2014 Aug |
2 |